Literature DB >> 3421162

Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor.

M P Savage1, A S Krolewski, G G Kenien, M P Lebeis, A R Christlieb, S M Lewis.   

Abstract

Diabetes mellitus has been associated with high mortality rates in patients with acute myocardial infarction (AMI). To better define prognosis in this population, the clinical course of 183 diabetics with AMI was studied. In-hospital mortality for all patients was 28% (52 of 183 patients). Mortality was significantly higher in patients with prior AMI than in patients without prior AMI (41 vs 18%, p less than 0.01) and was significantly higher in women than in men (37 vs 19%, p less than 0.01). The 2-fold increase in mortality among diabetic women was observed both in patients with and without prior AMI. The excess mortality among diabetic women was attributable to their increased risk for severe congestive heart failure (CHF) and cardiogenic shock. Death due to CHF occurred in 22% of all diabetic women with AMI compared with 6% of the diabetic men (p less than 0.01). Death resulting from complications other than CHF was similar for both sexes. There were no male-female differences in the history of prior AMI, systemic hypertension, obesity, nephropathy, frequency of Q-wave AMI, anterior AMI or peak creatine kinase levels to account for the high risk for CHF in diabetic women. It is therefore concluded that diabetic women with AMI are at increased risk for death due to CHF, and that this risk is not readily attributable to known conditions associated with CHF.

Entities:  

Mesh:

Year:  1988        PMID: 3421162     DOI: 10.1016/0002-9149(88)91199-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

Review 1.  acp Best Practice No 168. The investigation and management of obesity.

Authors:  M Labib
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

2.  Insulin infusion in diabetic patients with acute myocardial infarction.

Authors:  G Davey; P Mckeigue
Journal:  BMJ       Date:  1996-09-14

Review 3.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

4.  Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.

Authors:  Manisha Gupte; Hind Lal; Firdos Ahmad; Douglas B Sawyer; Michael F Hill
Journal:  J Card Fail       Date:  2017-09-04       Impact factor: 5.712

Review 5.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

6.  Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.

Authors:  Cheng-Chun Wei; Kou-Gi Shyu; Jun-Jack Cheng; Hei-Ming Lo; Chiung-Zuan Chiu
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

Review 7.  Cardiovascular disease risk in youth with diabetes mellitus.

Authors:  R Paul Wadwa
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

8.  Effects of acute hyperglycemia on the exercise pressor reflex in healthy rats.

Authors:  Yu Huo; Ann-Katrin Grotle; Kai M Ybarbo; Junghoon Lee; Michelle L Harrison; Audrey J Stone
Journal:  Auton Neurosci       Date:  2020-11-05       Impact factor: 3.145

Review 9.  Coronary heart disease in women: why the disproportionate risk?

Authors:  Helen Colhoun
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

Review 10.  Atypical presentation of acute and chronic coronary artery disease in diabetics.

Authors:  Hadi Ar Hadi Khafaji; Jassim M Al Suwaidi
Journal:  World J Cardiol       Date:  2014-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.